1,427 results on '"Lanctôt, Krista L."'
Search Results
52. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers
53. The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect
54. Apathy as a Treatment Target in Alzheimer's Disease: Implications For Clinical Trials
55. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
56. Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments
57. Criteria for Psychosis in Major and Mild Neurocognitive Disorders: International Psychogeriatric Association (IPA) Consensus Clinical and Research Definition
58. Serum osteocalcin is associated with subjective stress in people with depression and type 2 diabetes
59. Apathy in Alzheimer’s Disease
60. Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
61. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
62. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
63. Antidepressant-placebo differences for specific adverse events in major depressive disorder: A systematic review
64. A Literature Review on the Burden of Alzheimer’s Disease on Care Partners
65. Self- versus informant-report of cognitive decline in mild cognitive impairment: Concordance with cognitive and functional performance.
66. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes
67. Randomized Placebo-Controlled Trial of Nabilone for Agitation in Alzheimer's Disease
68. Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
69. Modifiable Risk Factors Associated With Cognitive Decline in Late Life Depression: Findings From the Canadian Longitudinal Study on Aging: Facteurs de risque modifiables associés au déclin cognitif dans la dépression en fin de vie : constatations de l'Étude longitudinale canadienne sur le vieillissement
70. Novel Pharmacologic Strategies for Treating Behavioral Disturbances in Alzheimer’s Disease
71. The Roles of Apathy and Depression in Predicting Alzheimer Disease: A Longitudinal Analysis in Older Adults With Mild Cognitive Impairment
72. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need
73. Longitudinal associations between 4-hydroxynonenal and depression in coronary artery disease patients
74. The effect of exercise on resting concentrations of peripheral brain-derived neurotrophic factor (BDNF) in major depressive disorder: A meta-analysis
75. Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review
76. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes.
77. Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future.
78. Attentional impairments to novel images in dementia
79. Contributors
80. Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke
81. Pharmacotherapy of Dementia
82. Evidence for Inflammation-Associated Depression
83. Global grey matter volume in adult bipolar patients with and without lithium treatment: A meta-analysis
84. Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
85. Respiratory illness and respiratory syncytial virus hospitalization in infants with a tracheostomy following prophylaxis with palivizumab
86. Current Agents in Development for Treating Behavioral and Psychological Symptoms Associated with Dementia
87. Update on the Risk of Motor Vehicle Collision or Driving Impairment with Dementia: A Collaborative International Systematic Review and Meta-Analysis
88. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease
89. Association of sulfonylureas with the risk of dementia: A population‐based cohort study
90. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease
91. Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)
92. A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
93. Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes
94. Longitudinal relationships between depressive symptoms, functional impairment, and physical activity in later late life
95. Ceramides and depression: A systematic review
96. Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients
97. Apathy associated with neurocognitive disorders: Recent progress and future directions
98. Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33–35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study
99. Respiratory Syncytial Virus Prophylaxis in Immunocompromised Children: Outcomes From the Canadian RSV Evaluation Study of Palivizumab Registry Over Twelve Seasons (2005–2017)
100. Association between endothelial function and cognitive performance in patients with coronary artery disease during cardiac rehabilitation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.